NMPA Product

Compound Sulfadiazine Tablets

Product approved by National Medical Products Administration (CN)

Basic Information

Product Name

Compound Sulfadiazine Tablets

Generic Name

复方磺胺嘧啶片

Strength

磺胺嘧啶0.4g;甲氧苄啶50mg

Dosage Form

片剂

Regulatory Information

Approval Number

国药准字H21020772

Approval StatusApproved

Drug Type

化学药品

Approval Date

August 26, 2020

Company Information

Manufacturer辽宁绿丹药业有限公司

Production Company辽宁绿丹药业有限公司

Active Ingredients

Compound Sulfadiazine Tablets

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy